ROCK2 and inflammatory bowel disease: Since D and DA stay intact in the gastrointestinal lumen and mesentery vessels draining into the hepatic portal vein system (Fig. 2), they may directly inhibit ROCK2 activity on site to contribute to their (and AGN’s) observed ameliorating actions on IBD models.